Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
306.255880332
InChI
InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-
InChI Key
InChIKey=HOBAELRKJCKHQD-QNEBEIHSSA-N
IUPAC Name
(8Z,11Z,14Z)-icosa-8,11,14-trienoic acid
Traditional IUPAC Name
gamma-homolinolenic acid
SMILES
CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O
pKa (strongest acidic)
4.89
Refractivity
98.84 m3·mol-1
Dược Lực Học :
Dihomo gamma-linolenic acid or DHLA is an n-6 (omega-6) polyunsaturated fatty acid. It is comprised of 20 carbon atoms and three double bonds. DHLA is a byproduct of the 18 carbon gamma-linolenic acid (GLA). DHLA is then converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect.
Cơ Chế Tác Dụng :
A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. [PubChem]
DHLA (or DGLA) is a precursor in the synthesis of prostaglandin E1 (PGE1) as well as the series-3 prostaglandins. It also serves as a precursor in the synthesis of eicosapentaenoic acid (EPA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-thrombogenic, anti-inflammatory and anti-atherogenic properties. PGE1 inhibits platelet aggregation and has a vasodilation action. DHLA has also been shown to reduce the production/activity of tumor necrosis factor alpha.
Chỉ Định :
For nutritional supplementation, also for treating dietary shortage or imbalance
Liều Lượng & Cách Dùng :
Capsule - Oral